How New Interventions Become Approved
Clinical Trials in the U.S. are carefully controlled research studies that test new medical treatments, drugs, or devices for safety and effectiveness. They follow a structured process divided into phases:
- Phase I: Test safety and dosage in a small group (20-80 participants)
- Phase II: Expands to hundreds of participants with the target condition to assess efficacy and side effects.
- Phase III: Involves thousands of participants to confirm effectiveness, monitor side effects, and compare with existing treatments.
- Phase IV (Post-Market): Occurs after FDA approval to track long-term effects in the general population.
Before any trial begins, researchers submit detailed plans (protocols) to the FDA and an Institutional Review Board (IRB) to ensure ethical standards and participant safety. Participants must provide informed consent and can withdraw at any time. Trials may be randomized, blinded, or placebo-controlled to reduce bias while preserving safety. Successful Phase III results can lead to FDA approval, making the treatment available to the general public. Clinical trials are vital for medical progress, offering patients access to cutting-edge therapies, while advancing global healthcare knowledge.
HonorHealth Research Institute: Committed to Ethical, Compliant Clinical Research
HonorHealth Research Institute conducts high-quality clinical trials, while strictly adhering to federal, state and local laws, regulatory guidelines, and ethical standards. Oversight includes IRB review, FDA compliance, and Good Clinical Practice (GCP). Studies follow rigorous protocols, ensuring participant safety, data integrity, and informed consent. The Research Institute maintains HIPAA compliance, investigator training, and quality monitoring to uphold research excellence. By integrating regulatory expertise with patient-centered care, HonorHealth is helping advance medical innovation responsibly throughout the Research Institute.